These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28515225)

  • 1. Energy metabolic pathways control the fate and function of myeloid immune cells.
    Al-Khami AA; Rodriguez PC; Ochoa AC
    J Leukoc Biol; 2017 Aug; 102(2):369-380. PubMed ID: 28515225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic regulation of innate immunity.
    Liang S; Ji L; Kang L; Hu X
    Adv Immunol; 2020; 145():129-157. PubMed ID: 32081196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.
    Hundertmark J; Krenkel O; Tacke F
    Front Immunol; 2018; 9():2418. PubMed ID: 30405618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses.
    Stienstra R; Netea-Maier RT; Riksen NP; Joosten LAB; Netea MG
    Cell Metab; 2017 Jul; 26(1):142-156. PubMed ID: 28683282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intersection of Epigenetics and Metabolism in Trained Immunity.
    Fanucchi S; Domínguez-Andrés J; Joosten LAB; Netea MG; Mhlanga MM
    Immunity; 2021 Jan; 54(1):32-43. PubMed ID: 33220235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells: linking inflammation and cancer.
    Ostrand-Rosenberg S; Sinha P
    J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis.
    Liu G; Bi Y; Shen B; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Liao J; Chen X; Chu Y
    Cancer Res; 2014 Feb; 74(3):727-37. PubMed ID: 24351289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Role of Metabolism in Regulating Immune Cell Fate Decisions.
    Ohradanova-Repic A; Boes M; Stockinger H
    Front Immunol; 2020; 11():527. PubMed ID: 32265941
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic Reprogramming in Mitochondria of Myeloid Cells.
    Zuo H; Wan Y
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of myeloid cell differentiation, identity and function.
    Álvarez-Errico D; Vento-Tormo R; Sieweke M; Ballestar E
    Nat Rev Immunol; 2015 Jan; 15(1):7-17. PubMed ID: 25534619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of metabolism-driven myeloid dysfunctions in cancer therapy.
    Strauss L; Guarneri V; Gennari A; Sica A
    Cell Mol Immunol; 2021 Apr; 18(4):829-841. PubMed ID: 33077904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
    Abrams SI; Netherby CS; Twum DY; Messmer MN
    J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions.
    Bronte V
    Eur J Immunol; 2009 Oct; 39(10):2670-2. PubMed ID: 19757440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system.
    Laslo P; Pongubala JM; Lancki DW; Singh H
    Semin Immunol; 2008 Aug; 20(4):228-35. PubMed ID: 18771937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemozoin Enhances Maturation of Murine Bone Marrow Derived Macrophages and Myeloid Dendritic Cells.
    Waseem S; Ur-Rehman K; Kumar R; Mahmood T
    Iran J Immunol; 2016 Mar; 13(1):1-8. PubMed ID: 27026041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and function.
    van de Laar L; van den Bosch A; van der Kooij SW; Janssen HL; Coffer PJ; van Kooten C; Woltman AM
    J Immunol; 2010 Dec; 185(12):7252-61. PubMed ID: 21076069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFI-A disrupts myeloid cell differentiation and maturation in septic mice.
    McClure C; Ali E; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2016 Jan; 99(1):201-11. PubMed ID: 26259914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology.
    Sica A; Strauss L
    J Leukoc Biol; 2017 Aug; 102(2):325-334. PubMed ID: 28223316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
    Yaddanapudi K; Rendon BE; Lamont G; Kim EJ; Al Rayyan N; Richie J; Albeituni S; Waigel S; Wise A; Mitchell RA
    Cancer Immunol Res; 2016 Feb; 4(2):101-12. PubMed ID: 26603621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.